0.4788
price down icon12.63%   -0.0692
after-market Handel nachbörslich: .53 0.0512 +10.69%
loading
Schlusskurs vom Vortag:
$0.548
Offen:
$0.5218
24-Stunden-Volumen:
583.33K
Relative Volume:
0.11
Marktkapitalisierung:
$2.51M
Einnahmen:
$735.20K
Nettoeinkommen (Verlust:
$-9.70M
KGV:
-0.0011
EPS:
-435.729
Netto-Cashflow:
$-9.80M
1W Leistung:
-22.77%
1M Leistung:
-27.83%
6M Leistung:
-93.70%
1J Leistung:
-99.72%
1-Tages-Spanne:
Value
$0.4625
$0.5299
1-Wochen-Bereich:
Value
$0.4625
$0.6007
52-Wochen-Spanne:
Value
$0.4625
$200.00

Onconetix Inc Stock (ONCO) Company Profile

Name
Firmenname
Onconetix Inc
Name
Telefon
513-620-4101
Name
Adresse
201 E. FIFTH STREET, CINCINNATI
Name
Mitarbeiter
8
Name
Twitter
Name
Nächster Verdiensttermin
2026-11-12
Name
Neueste SEC-Einreichungen
Name
ONCO's Discussions on Twitter

Compare ONCO vs VRTX, MRNA, REGN, ARGX, ONC

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
ONCO icon
ONCO
Onconetix Inc
0.4788 2.51M 735.20K -9.70M -9.80M -435.73
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
499.74 126.66B 12.34B 4.34B 3.71B 16.87
MRNA icon
MRNA
Moderna Inc
218.01 87.04B 2.23B -3.19B -1.60B -8.1462
REGN icon
REGN
Regeneron Pharmaceuticals Inc
790.74 81.41B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
819.14 51.51B 4.16B 1.29B 734.26M 19.58
ONC icon
ONC
Beone Medicines Ltd Adr
369.06 41.75B 5.76B 514.49M 1.10B 4.4813

Onconetix Inc Aktie (ONCO) Neueste Nachrichten

pulisher
Oct 09, 2026

Onconetix, Inc. (ONCO) — share price and filings - Howl.link

Oct 09, 2026
pulisher
Oct 08, 2026

12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

Oct 08, 2026
pulisher
Oct 07, 2026

Five proposals face a November 10 vote as Onconetix (ONCO) asks for another reverse split. - Stock Titan

Oct 07, 2026
pulisher
Sep 14, 2026

Onconetix (NASDAQ: ONCO) must clear a cash hurdle to close its Realbotix takeover - Stock Titan

Sep 14, 2026
pulisher
Sep 14, 2026

CORRECTED: Onconetix Provides Strategic Bridge Financing to Realbotix LLC in Support of Pending Acquisition - Stock Titan

Sep 14, 2026
pulisher
Sep 14, 2026

Onconetix Provides Strategic Bridge Financing to Realbotix LLC in Support of Pending Acquisition - The Manila Times

Sep 14, 2026
pulisher
Sep 14, 2026

Onconetix Provides $2.5 Million Bridge Financing to Realbotix Ahead of Pending Acquisition - Quiver Quantitative

Sep 14, 2026
pulisher
Sep 08, 2026

Onconetix Inc (NASDAQ: ONCO) Share Price, ONCO Stock News, ONCO Share Price & Updates - Kalkine

Sep 08, 2026
pulisher
Sep 07, 2026

Could Onconetix (NASDAQ:ONCO) Face More Volatility on Nasdaq? - Kalkine Media

Sep 07, 2026
pulisher
Sep 04, 2026

Stay updated with the stocks that are on the move in today's after-hours session. - ChartMill

Sep 04, 2026
pulisher
Sep 04, 2026

Onconetix Inc Peer Comparison – Compare with Others - Value Research

Sep 04, 2026
pulisher
Sep 04, 2026

Onconetix, Inc. SEC Filing (Sep 4, 2026) - Stock Titan

Sep 04, 2026
pulisher
Sep 03, 2026

Onconetix Acquisition Target Realbotix Launches Pilot with Leading European Telecommunications Company to Deploy Humanoid Robots in Live Presentations and Events - Yahoo Finance

Sep 03, 2026
pulisher
Sep 03, 2026

Humanoid robot presenters get live trial as Onconetix (NASDAQ: ONCO) pursues Realbotix buyout - Stock Titan

Sep 03, 2026
pulisher
Aug 31, 2026

Onconetix (NASDAQ: ONCO) flags going concern as 100M-share resale filed - Stock Titan

Aug 31, 2026
pulisher
Aug 28, 2026

Onconetix, Inc. (ONCO) Stock Price & News - syfe.com

Aug 28, 2026
pulisher
Aug 27, 2026

Onconetix Inc Key Financial Ratios – Valuation, Profitability & More - Value Research

Aug 27, 2026
pulisher
Aug 18, 2026

Onconetix (ONCO) Reported Quarter: Available Data Shows the Latest Reported Performance for This Review; Shares Move 0.95% Lower in Latest TradingReturn On Assets - dars.gov.et

Aug 18, 2026
pulisher
Aug 18, 2026

Onconetix (ONCO) Reported Quarter: Available Data Shows the Latest Reported Performance for This Review; Shares Move 0.95% Lower in Latest TradingGuidance Downgrade Alert - vinanet.vn

Aug 18, 2026
pulisher
Aug 18, 2026

Onconetix (ONCO) Reported Quarter: Available Data Shows the Latest Reported Performance for This Review; Shares Move 0.95% Lower in Latest TradingDividend Earnings Report - dars.gov.et

Aug 18, 2026
pulisher
Aug 13, 2026

Onconetix (ONCO) flags going concern risk as cash burn, impairments mount - Stock Titan

Aug 13, 2026
pulisher
Aug 13, 2026

Onconetix, Inc. (ONCO) Debt 2025 - Stock Titan

Aug 13, 2026
pulisher
Aug 12, 2026

Onconetix (NASDAQ: ONCO) resale filing covers 100M shares tied to PIPE - Stock Titan

Aug 12, 2026
pulisher
Aug 12, 2026

Realbotix Q3 Results: Revenue Falls 40%, Loss Widens Amid Scaling - scanx.trade

Aug 12, 2026
pulisher
Aug 12, 2026

Realbotix Plans Online-Only Robot Line With Buyer Deposits in 2026 - Stock Titan

Aug 12, 2026
pulisher
Aug 07, 2026

Onconetix Inc (ONCO) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com

Aug 07, 2026
pulisher
Aug 06, 2026

Onconetix Acquisition Target Realbotix Secures Agreement for Humanoid Robot Appearance on Emmy Award-Winning Streaming Series - The Manila Times

Aug 06, 2026
pulisher
Aug 06, 2026

Onconetix (ONCO) outlines Realbotix all-stock acquisition and humanoid robot TV role - Stock Titan

Aug 06, 2026
pulisher
Aug 06, 2026

Onconetix Acquisition Target Realbotix Secures Agreement for Humanoid Robot Appearance on Emmy Award-Winning Streaming Series - GlobeNewswire

Aug 06, 2026
pulisher
Aug 06, 2026

Onconetix Acquisition Target Realbotix Secures Agreement for Humanoid Robot Appearance on Emmy Award-Winning Streaming Series - Yahoo Finance

Aug 06, 2026
pulisher
Aug 05, 2026

Onconetix subsidiary appoints co-founder to board - Investing.com

Aug 05, 2026
pulisher
Aug 05, 2026

Onconetix subsidiary appoints co-founder to board By Investing.com - Investing.com Nigeria

Aug 05, 2026
pulisher
Aug 05, 2026

Onconetix subsidiary appoints co-founder to board By Investing.com - Investing.com Canada

Aug 05, 2026
pulisher
Aug 05, 2026

Onconetix subsidiary appoints co-founder to board By Investing.com - Investing.com South Africa

Aug 05, 2026
pulisher
Aug 05, 2026

Onconetix Announces Appointment of Ralph Schiess, PhD to Board of Directors of Proteomedix AG - The Manila Times

Aug 05, 2026
pulisher
Aug 05, 2026

Onconetix subsidiary appoints co-founder to board By Investing.com - Investing.com UK

Aug 05, 2026
pulisher
Aug 05, 2026

Onconetix Announces Appointment of Ralph Schiess, PhD to Board of Directors of Proteomedix AG - Caledonian Record

Aug 05, 2026
pulisher
Aug 05, 2026

Onconetix Announces Appointment of Ralph Schiess, PhD to Board of Directors of Proteomedix AG - GlobeNewswire

Aug 05, 2026
pulisher
Aug 02, 2026

ONCO Q1 2025 Earnings: Positive EPS of $0.25 Marks a Notable Bottom-Line QuarterBanking Earnings Report - vinanet.vn

Aug 02, 2026
pulisher
Jul 31, 2026

Onconetix Inc (ONCO) Financial Health: Profitability & Balance Sheet Analysis - tradingkey.com

Jul 31, 2026
pulisher
Jul 30, 2026

Onconetix Secures Major PIPE and Equity Facility Financing - The Globe and Mail

Jul 30, 2026
pulisher
Jul 29, 2026

12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga

Jul 29, 2026
pulisher
Jul 29, 2026

Onconetix (NASDAQ: ONCO) adds $750,000,000 ELOC and $30,249,600 PIPE - Stock Titan

Jul 29, 2026
pulisher
Jul 27, 2026

Onconetix (ONCO) 13G: Keystone Capital reports 6.1% beneficial stake - Stock Titan

Jul 27, 2026
pulisher
Jul 27, 2026

Onconetix Inc. (ONCO) Gains 3.46% as Shares Approach Resistance at $0.89Factor Timing - dars.gov.et

Jul 27, 2026
pulisher
Jul 27, 2026

Onconetix Inc (ONCO) Balance Sheet - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Onconetix Inc. (ONCO) Gains 3.46% as Shares Approach Resistance at $0.89Intraday Trade Ideas - vinanet.vn

Jul 27, 2026
pulisher
Jul 26, 2026

Onconetix Inc (ONCO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 26, 2026
pulisher
Jul 26, 2026

Onconetix Inc (ONCO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jul 26, 2026
pulisher
Jul 26, 2026

Onconetix Inc (ONCO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jul 26, 2026

Finanzdaten der Onconetix Inc-Aktie (ONCO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Onconetix Inc-Aktie (ONCO) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
HRT FINANCIAL LP
10% Owner
Apr 20 '26
Sale
0.75
94,462
70,846
83,359
HRT FINANCIAL LP
10% Owner
Apr 17 '26
Buy
0.73
34,636
25,284
177,821
HRT FINANCIAL LP
10% Owner
Apr 16 '26
Sale
0.73
53,867
39,323
143,185
HRT FINANCIAL LP
10% Owner
Apr 15 '26
Buy
0.76
92,554
70,341
197,052
HRT FINANCIAL LP
10% Owner
Apr 14 '26
Buy
0.77
74,350
57,250
104,498
$6.58
price down icon 4.22%
$9.94
price down icon 3.21%
$5.53
price down icon 3.66%
$11.27
price down icon 6.16%
$18.60
price down icon 1.74%
WVE WVE
$3.13
price down icon 1.88%
Kapitalisierung:     |  Volumen (24h):